{'fraction_non_alphanumeric': 0.022304832713754646, 'fraction_numerical': 0.013630731102850062, 'mean_word_length': 5.516129032258065, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Decreased levels of serum nesfatin-1 in patients with preeclampsia

Abstract Context: Nesfatin-1 is implicated to possess an anti-inflammatory effect. Objective: The aim of our study is to investigate whether abnormal serum levels of nesfatin-1 are associated with the presence and severity of preeclampsia. Methods: A total of 120 women with preeclampsia and 92 women with uncomplicated pregnancies were enrolled in this study. Results: Women with preeclampsia showed significantly reduced levels of serum nesfatin-1 levels than women with uncomplicated pregnancies. Serum nesfatin-1 levels were significantly decreased in women with severe preeclampsia compared with women with mild preeclampsia. Conclusion: Decreased serum nesfatin-1 levels are associated with the presence and severity of preeclampsia.